BioCentury
ARTICLE | Product Development

Medicxi’s de Rubertis hopes for positive future for infectious disease after COVID-19: a BioCentury audio interview

de Rubertis believes COVID-19 could be the trigger to push for legislative action on infectious disease incentives

September 10, 2020 2:10 AM UTC

Francesco de Rubertis, co-founder and partner of Medicxi, is optimistic that the COVID-19 pandemic might lead to an increased interest in infectious disease investment, but it will take government action to create the incentives.

de Rubertis spoke to BioCentury on an audio interview as part of the Back to School 2020 series (see Cover Story: “Back to School 2020”). ...